PubMed:32853672
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 58-66 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T2 | 171-195 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T3 | 197-205 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 410-418 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T5 | 655-670 | Disease | denotes | cardiac disease | http://purl.obolibrary.org/obo/MONDO_0005267 |
| T6 | 1623-1633 | Disease | denotes | arrhythmia | http://purl.obolibrary.org/obo/MONDO_0007263 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 76-81 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T2 | 141-144 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T3 | 288-289 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T4 | 323-328 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
| T5 | 420-421 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T6 | 1480-1481 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T7 | 1584-1585 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 28-40 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T2 | 76-81 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T3 | 248-260 | Chemical | denotes | azithromycin | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T4 | 262-265 | Chemical | denotes | AZM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T5 | 323-328 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
| T6 | 458-463 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T7 | 474-492 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
| T8 | 503-522 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T9 | 503-512 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
| T10 | 513-522 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T11 | 574-579 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T12 | 630-633 | Chemical | denotes | AZM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T13 | 737-742 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T14 | 829-832 | Chemical | denotes | ACC | http://purl.obolibrary.org/obo/CHEBI_18053|http://purl.obolibrary.org/obo/CHEBI_30526 |
| T16 | 861-864 | Chemical | denotes | AZM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T17 | 1332-1337 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
| T18 | 1443-1446 | Chemical | denotes | AZM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T19 | 1512-1515 | Chemical | denotes | AZM | http://purl.obolibrary.org/obo/CHEBI_2955 |
| T20 | 1647-1650 | Chemical | denotes | ACC | http://purl.obolibrary.org/obo/CHEBI_18053|http://purl.obolibrary.org/obo/CHEBI_30526 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 28-40 | Chemical | denotes | azithromycin | MESH:D017963 |
| 4 | 44-52 | Species | denotes | patients | Tax:9606 |
| 5 | 58-66 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 34 | 171-195 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
| 35 | 197-205 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 36 | 248-260 | Chemical | denotes | azithromycin | MESH:D017963 |
| 37 | 262-265 | Chemical | denotes | AZM | MESH:D017963 |
| 38 | 276-284 | Species | denotes | patients | Tax:9606 |
| 39 | 375-383 | Species | denotes | patients | Tax:9606 |
| 40 | 410-418 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 41 | 434-442 | Species | denotes | patients | Tax:9606 |
| 42 | 474-492 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 43 | 494-497 | Chemical | denotes | HCQ | MESH:D006886 |
| 44 | 503-522 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 45 | 524-529 | Chemical | denotes | LPV/r | MESH:C558899 |
| 46 | 553-561 | Species | denotes | patients | Tax:9606 |
| 47 | 630-633 | Chemical | denotes | AZM | MESH:D017963 |
| 48 | 635-643 | Species | denotes | Patients | Tax:9606 |
| 49 | 655-670 | Disease | denotes | cardiac disease | MESH:D006331 |
| 50 | 714-722 | Species | denotes | patients | Tax:9606 |
| 51 | 761-778 | Disease | denotes | cardiac arrythmia | MESH:D001145 |
| 52 | 861-864 | Chemical | denotes | AZM | MESH:D017963 |
| 53 | 869-872 | Chemical | denotes | HCQ | MESH:D006886 |
| 54 | 1014-1023 | Disease | denotes | mortality | MESH:D003643 |
| 55 | 1382-1391 | Disease | denotes | mortality | MESH:D003643 |
| 56 | 1421-1429 | Species | denotes | Patients | Tax:9606 |
| 57 | 1443-1446 | Chemical | denotes | AZM | MESH:D017963 |
| 58 | 1462-1465 | Chemical | denotes | HCQ | MESH:D006886 |
| 59 | 1470-1475 | Chemical | denotes | LPV/r | MESH:C558899 |
| 60 | 1508-1515 | Chemical | denotes | HCQ+AZM | |
| 61 | 1615-1633 | Disease | denotes | cardiac arrhythmia | MESH:D001145 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 1615-1633 | Phenotype | denotes | cardiac arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-67 | Sentence | denotes | Safety and effectiveness of azithromycin in patients with COVID-19: |
| T2 | 68-99 | Sentence | denotes | An open-label randomised trial. |
| T3 | 100-314 | Sentence | denotes | As no specific pharmacological treatment has been validated for use in coronavirus disease 2019 (COVID-19), we aimed to assess the effectiveness of azithromycin (AZM) in these patients at a referral centre in Iran. |
| T4 | 315-419 | Sentence | denotes | An open-label, randomised controlled trial was conducted on patients with laboratory-confirmed COVID-19. |
| T5 | 420-634 | Sentence | denotes | A total of 55 patients in the control group receiving hydroxychloroquine (HCQ) and lopinavir/ritonavir (LPV/r) were compared with 56 patients in the case group who in addition to the same regimen also received AZM. |
| T6 | 635-700 | Sentence | denotes | Patients with prior cardiac disease were excluded from the study. |
| T7 | 701-873 | Sentence | denotes | Furthermore, patients from the case group were assessed for cardiac arrythmia risk based on the American College of Cardiology (ACC) risk assessment for use of AZM and HCQ. |
| T8 | 874-1077 | Sentence | denotes | The main outcome measures were vital signs, SpO2 levels, duration of hospitalisation, need for and length of intensive care unit admission, mortality rate and results of 30-day follow-up after discharge. |
| T9 | 1078-1190 | Sentence | denotes | Initially, there was no significant difference between the general conditions and vital signs of the two groups. |
| T10 | 1191-1338 | Sentence | denotes | The SpO2 levels at discharge were significantly higher, the respiratory rate was lower and the duration of admission was shorter in the case group. |
| T11 | 1339-1420 | Sentence | denotes | There was no significant difference in the mortality rate between the two groups. |
| T12 | 1421-1507 | Sentence | denotes | Patients who received AZM in addition to HCQ and LPV/r had a better general condition. |
| T13 | 1508-1660 | Sentence | denotes | HCQ+AZM combination may be beneficial for individuals who are known to have a very low underlying risk for cardiac arrhythmia based on the ACC criteria. |
hydroxychloroquine
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 1615-1633 | Phenotype | denotes | cardiac arrhythmia | http://purl.obolibrary.org/obo/HP_0011675 |